According to the announcement of Scantech, from January to June 2026, it achieved operating income of 185 million yuan, an increase of 4.67%; net profit attributable to shareholders of listed companies was 14.125 million yuan, a year-on-year decrease of 73.85%; net profit after deducting non-recurring profit and loss was 886.49 million yuan, a year-on-year decrease of 81.17%. The lower revenue growth rate is mainly due to the overseas ODM customer law, such as a sharp decrease in the purchase amount in the current period. After excluding the impact of this customer, revenue increased 15.54% year on year. The decline in net profit was mainly due to increased investment in R&D, expansion of sales networks, calculation of share payment expenses, and increased expenses during the period due to exchange losses. The total R&D investment during the reporting period was 61.9073 million yuan, accounting for 33.45% of revenue, an increase of 11.93 percentage points over the previous year.

According to the announcement of Scantech, from January to June 2026, it achieved operating income of 185 million yuan, an increase of 4.67%; net profit attributable to shareholders of listed companies was 14.125 million yuan, a year-on-year decrease of 73.85%; net profit after deducting non-recurring profit and loss was 886.49 million yuan, a year-on-year decrease of 81.17%. The lower revenue growth rate is mainly due to the overseas ODM customer law, such as a sharp decrease in the purchase amount in the current period. After excluding the impact of this customer, revenue increased 15.54% year on year. The decline in net profit was mainly due to increased investment in R&D, expansion of sales networks, accounting of share payment expenses, and increased expenses during the period due to exchange losses. The total R&D investment during the reporting period was 61.9073 million yuan, accounting for 33.45% of revenue, an increase of 11.93 percentage points over the previous year.